company background image
000739 logo

Apeloa PharmaceuticalLtd SZSE:000739 Stock Report

Last Price

CN¥16.95

Market Cap

CN¥19.8b

7D

1.6%

1Y

0.4%

Updated

13 Nov, 2024

Data

Company Financials +

Apeloa Pharmaceutical Co.,Ltd

SZSE:000739 Stock Report

Market Cap: CN¥19.8b

000739 Stock Overview

Provides raw materials and intermediates to various pharmaceutical factories in the People’s Republic of China and internationally.

000739 fundamental analysis
Snowflake Score
Valuation5/6
Future Growth1/6
Past Performance2/6
Financial Health5/6
Dividends4/6

Apeloa Pharmaceutical Co.,Ltd Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Apeloa PharmaceuticalLtd
Historical stock prices
Current Share PriceCN¥16.95
52 Week HighCN¥18.96
52 Week LowCN¥10.66
Beta0.057
11 Month Change2.29%
3 Month Change13.99%
1 Year Change0.41%
33 Year Change-57.66%
5 Year Change34.84%
Change since IPO934.69%

Recent News & Updates

Apeloa Pharmaceutical Co.,Ltd (SZSE:000739) Looks Inexpensive But Perhaps Not Attractive Enough

Nov 09
Apeloa Pharmaceutical Co.,Ltd (SZSE:000739) Looks Inexpensive But Perhaps Not Attractive Enough

Apeloa PharmaceuticalLtd (SZSE:000739) Seems To Use Debt Quite Sensibly

Sep 30
Apeloa PharmaceuticalLtd (SZSE:000739) Seems To Use Debt Quite Sensibly

Recent updates

Apeloa Pharmaceutical Co.,Ltd (SZSE:000739) Looks Inexpensive But Perhaps Not Attractive Enough

Nov 09
Apeloa Pharmaceutical Co.,Ltd (SZSE:000739) Looks Inexpensive But Perhaps Not Attractive Enough

Apeloa PharmaceuticalLtd (SZSE:000739) Seems To Use Debt Quite Sensibly

Sep 30
Apeloa PharmaceuticalLtd (SZSE:000739) Seems To Use Debt Quite Sensibly

Lacklustre Performance Is Driving Apeloa Pharmaceutical Co.,Ltd's (SZSE:000739) Low P/E

Aug 07
Lacklustre Performance Is Driving Apeloa Pharmaceutical Co.,Ltd's (SZSE:000739) Low P/E

Is Apeloa PharmaceuticalLtd (SZSE:000739) Using Too Much Debt?

Jun 24
Is Apeloa PharmaceuticalLtd (SZSE:000739) Using Too Much Debt?

Apeloa Pharmaceutical Co.,Ltd's (SZSE:000739) Share Price Boosted 26% But Its Business Prospects Need A Lift Too

May 08
Apeloa Pharmaceutical Co.,Ltd's (SZSE:000739) Share Price Boosted 26% But Its Business Prospects Need A Lift Too

Shareholder Returns

000739CN PharmaceuticalsCN Market
7D1.6%3.9%2.7%
1Y0.4%0.6%8.7%

Return vs Industry: 000739 matched the CN Pharmaceuticals industry which returned 0.6% over the past year.

Return vs Market: 000739 underperformed the CN Market which returned 8.7% over the past year.

Price Volatility

Is 000739's price volatile compared to industry and market?
000739 volatility
000739 Average Weekly Movement5.4%
Pharmaceuticals Industry Average Movement7.1%
Market Average Movement8.0%
10% most volatile stocks in CN Market12.2%
10% least volatile stocks in CN Market5.4%

Stable Share Price: 000739 has not had significant price volatility in the past 3 months compared to the CN market.

Volatility Over Time: 000739's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19897,208Chun Hewww.apeloa.com

Apeloa Pharmaceutical Co.,Ltd provides raw materials and intermediates to various pharmaceutical factories in the People’s Republic of China and internationally. The company offers preparation products, including cardio-cerebrovascular, anti-infection, anti-tumor, anti-viral, and special drugs. It offers its products under the Tianliwei, Beshin, Yosemade, Jutai, and other brands.

Apeloa Pharmaceutical Co.,Ltd Fundamentals Summary

How do Apeloa PharmaceuticalLtd's earnings and revenue compare to its market cap?
000739 fundamental statistics
Market capCN¥19.84b
Earnings (TTM)CN¥1.07b
Revenue (TTM)CN¥12.26b

18.3x

P/E Ratio

1.6x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
000739 income statement (TTM)
RevenueCN¥12.26b
Cost of RevenueCN¥9.44b
Gross ProfitCN¥2.83b
Other ExpensesCN¥1.75b
EarningsCN¥1.07b

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.93
Gross Margin23.06%
Net Profit Margin8.75%
Debt/Equity Ratio14.3%

How did 000739 perform over the long term?

See historical performance and comparison

Dividends

1.9%

Current Dividend Yield

34%

Payout Ratio